Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Healthlead PCLBKK:HL 72 Days Inventory is 69.44 as of Mar. 2026, which is 10% above its 10-year median of 63.03. GuruFocus rates BKK:HL with a GF Score™ of 72/100 and a GF Value™ of ฿10.89 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 497 Healthcare Providers & Services companies, Healthlead PCL ranks worse than 75.05% on this metric.
The historical rank and industry rank for Healthlead PCL's Days Inventory or its related term are showing as below:
BKK:HL'
s Days Inventory Range Over the Past 10 Years
Min: 57.41 Med: 63.03 Max: 70.03
Current: 69.67
During the past 7 years, Healthlead PCL's highest Days Inventory was 70.03. The lowest was 57.41. And the median was 63.03.
BKK:HL's Days Inventory is ranked worse than 75.05% of 497
companies
in the Healthcare Providers & Services industry
Industry Median: 29.67
vs BKK:HL: 69.67
Healthlead PCL's Days Inventory
increased
from Mar. 2025 (63.86) to Mar. 2026 (69.44).
It might indicate that Healthlead PCL's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Healthlead PCL's Inventory Turnover for the
three
months ended in Mar. 2026 was 1.31.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Healthlead PCL's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.58.
Healthlead PCL (BKK:HL) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Healthlead PCL's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Healthlead PCL's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Healthlead PCL Days Inventory Related Terms
Healthlead PCL Days Inventory Historical Data
* Premium members only.
The historical data trend for Healthlead PCL's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healthlead PCL Days Inventory Competitor Comparison
For the Pharmaceutical Retailers subindustry, Healthlead PCL's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Healthlead PCL Days Inventory vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Healthlead PCL's Days Inventory distribution charts can be found below:
* The bar in red indicates where Healthlead PCL's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healthlead PCL (BKK:HL) has a Days Inventory of 69.44 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Healthlead PCL and its competitors. This is 10% above median its historical median of 63.03. Over the past decade, Healthlead PCL's Days Inventory has ranged from 57.41 to 70.03. According to the industry distribution chart, Healthlead PCL ranks #373 out of 497 companies in the Healthcare Providers & Services industry, placing it in the top 75.1%.
Is Healthlead PCL's Days Inventory too high?
Healthlead PCL's current Days Inventory of 69.44 is 10% above median its 10-year median of 63.03. Over the past 10 years, this metric has ranged from a low of 57.41 to a high of 70.03. The Healthcare Providers & Services industry median Days Inventory is 29.67. Healthlead PCL's value of 69.44 is 134% above this industry median. Based on the distribution chart, Healthlead PCL ranks #373 out of 497 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Healthlead PCL has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Healthlead PCL's Days Inventory compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Healthlead PCL ranks #373 out of 497 companies for Days Inventory. This places Healthlead PCL in the lower half of its industry. The industry median Days Inventory is 29.67. Healthlead PCL's value of 69.44 is 134% above this benchmark. Historically, Healthlead PCL's own Days Inventory has ranged from 57.41 to 70.03 over the past decade. While the company's 10-year median is 63.03 vs. the industry median of 29.67, Healthlead PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Healthcare Providers & Services company?
The median Days Inventory among Healthcare Providers & Services companies is 29.67, based on 497 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Healthlead PCL's current Days Inventory of 69.44 is 134% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Healthlead PCL and its competitors. For the Healthcare Providers & Services industry, the median Days Inventory is 29.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Healthlead PCL's current Days Inventory is 69.44, which is 10% above median its own 10-year median of 63.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthlead PCL stock overvalued right now?
Based on GuruFocus' analysis, Healthlead PCL (BKK:HL) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿10.89, compared to a current price of ฿5.80 — trading 46.7% below its estimated fair value. The current Days Inventory is 69.44, which is 10% above median its 10-year median of 63.03 and 134% above the Healthcare Providers & Services industry median of 29.67. Healthlead PCL's overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Healthlead PCL (BKK:HL), the current Days Inventory is 69.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Healthlead PCL (BKK:HL) Overvalued in 2026?
Based on GuruFocus' analysis, Healthlead PCL stock appears to be undervalued.
The current stock price of ฿5.80 is trading 46.7% below its estimated GF Value™ of ฿10.89.
GuruFocus considers Healthlead PCL to be Significantly Undervalued.
Key valuation signals for BKK:HL:
Days Inventory: 69.44 (10% above median its 10-year median of 63.03)
GF Value™: ฿10.89 vs. price of ฿5.80 (46.7% below fair value)
Industry Position: 134% above the Healthcare Providers & Services median (#373 of 497)
No single metric tells the full story. See the BKK:HL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Healthlead PCL is a holding company. Along with its subsidiaries, it operates a pharmacy business under iCare, Pharmax, vitaminclub, and Super Drug brands, distributing medicines, medical supplies, cosmeceuticals, dietary supplements, medical devices, and other healthcare products. Additionally, it is involved in co-inventing and co-developing healthcare products in collaboration with external research teams and contract manufacturers, producing and distributing its own branded products. Geographically, the group operates only in Thailand.
72GF Score
Get the complete analysis for BKK:HL
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:HL has been successfully added to your 
